PPARA and infection: During hepatitis C virus (HCV) infection, PPAR-α/β/γ stimulators/agonists reduce calcitriol-mediated anti-HCV responses, presumably by counteracting the calcitriol-mediated activation of vitamin D receptor signaling and inhibiting nitrative stress [91].